Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biofusion expands University of Sheffield deal

This article was originally published in Scrip

Executive Summary

Biofusion, a UK university IP commercialisation company, has expanded its existing 10-year exclusive agreement with the University of Sheffield, UK, to include the rights to commercialise all non-life science research-generated intellectual property. It has also decided to change its name to Fusion IP to more accurately reflect its enlarged business. In addition, the company has raised just over £2 million before expenses through a placing of 2.3 shares at 90 pence each. The company's original agreement, which covers only life science-related IP, is due to expire in 2015.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC001536

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel